Effectiveness and safety of everolimus in the treatment of autoimmune hepatitis related to anti-hepatitis C virus therapy after liver transplant: Three case reports

Transplantation Proceedings

Volumn 43, Issue 6, 2011, Pages 2233-2236

  Casanovas, T ^a   Argudo, A ^a   Pena Cala M C ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; DACLIZUMAB; ERYTHROPOIETIN; EVEROLIMUS; GRANULOCYTE COLONY STIMULATING FACTOR; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON; PREDNISONE; RIBAVIRIN; SMOOTH MUSCLE ANTIBODY; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VALACICLOVIR;

ADULT; ANTIVIRAL THERAPY; ARTICLE; AUTOIMMUNE HEPATITIS; BIOCHEMISTRY; BRAIN HEMORRHAGE; CASE REPORT; CLINICAL FEATURE; CYTOPENIA; DEPRESSION; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DONOR; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HYPERTENSION; HYPERTRANSAMINASEMIA; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION; LIVER TRANSPLANTATION; MALE; OBESITY; PRIORITY JOURNAL; RECURRENT INFECTION; REMISSION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT DURATION; VIRUS LOAD;

ANTIVIRAL AGENTS; AZATHIOPRINE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FEMALE; HEPATITIS C; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERONS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDNISONE; RECURRENCE; RIBAVIRIN; SIROLIMUS; TREATMENT OUTCOME;

EID: 80051693610     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.05.028     Document Type: Article

References (28)

1. T. Bizollon, S.N. Ahmed, and S. Radenne Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis c virus recurrence Gut 52 2003 283
2. A. Kornberg, B. Kpper, and A. Tannapfel Sustained clearance of serum hepatitis C virus-RNA independently predicts long-term survival in liver transplant patients with recurrent hepatitis C Transplantation 86 2008 469
3. B.J. Veldt, J.J. Poterucha, and K.D. Watt Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection Am J Transplant 8 2008 2426
4. N. Kontorinis, K. Agarwal, and N. Elhajj Pegylated interferoninduced immune-mediated hepatitis post-liver transplantation Liver Transpl 12 2006 827
5. N. Kerkar, C. Dugan, and C. Rumbo Rapamune successfully treats post-transplant autoimmune hepatitis Am J Transplant 5 2005 1085
6. E.M. Hennes, M. Zeniya, A.J. Czaja International Autoimmune Hepatitis Group Simplified criteria for the diagnosis of autoimmune hepatitis Hepatology 48 2008 169
7. C.P. Strassburg Therapeutic options to treat autoimmune hepatitis in 2009 Dig Dis 28 2010 93
8. S.A. Schaffer, and H.J. Ross Everolimus: efficacy and safety in cardiac transplantation Expert Opin Drug Saf 9 2010 843
9. N. Manito, J.F. Delgado, and M.G. Crespo-Leiro Clinical recommendations for the use of everolimus in heart transplantation Transplant Rev (Orlando) 24 2010 129
10. A.I. Sánchez-Fructuoso, J.C. Ruiz, and I. Pérez-Flores Comparative analysis of adverse events requiring suspension of mTOR inhibitors: everolimus versus sirolimus Transplant Proc 42 2010 3050
11. A. Kessel, and E. Toubi Chronic HCV-related autoimmunity: a consequence of viral persistence and lymphotropism Curr Med Chem 14 2007 547
12. S. Asthana, C. Toso, and G. Meeberg The impact of sirolimus on hepatitis C recurrence after liver transplantation Can J Gastroenterol 25 2011 28
13. T. Kogure, Y. Ueno, and K. Fukushima Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment World J Gastroenterol 13 2007 4394
14. L. Merli, F. Gentili, and M. Giusto Immune liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis C: allo or autoimmune de novo hepatitis? Dig Liver Dis 41 2009 345
15. I. Aguilera, J.M. Sousa, and F. Gavilan Glutathione S-transferase T1 mismatch constitutes a risk factor for the novo immune hepatitis after liver transplantation Liver Transpl 10 2004 1166
16. S.C. Ward, T.D. Schiano, and S.N. Thung Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant Liver Transpl 15 2009 1826
17. U. Khettry, A. Backer, and G. Ayata Centrilobular histopathologic changes in liver transplant biopsies Hum Pathol 33 2002 270
18. M.I. Fiel, K. Agarwal, and C. Stanca Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus Liver Transpl 14 2008 861
19. A.J. Demetris, B. Eghtesad, and A. Marcos Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis Am J Surg Pathol 28 2004 658
20. M. Salcedo, J. Vaquero, and R. Baares Response to steroids in the novo autoimmune hepatitis after liver transplantation Hepatology 35 2002 349
21. L. Garcia-Buey, C. Garcia-Monzon, and S. Rodriguez Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C Gastroenterol 108 1995 1770
22. H. Tan, J. Derrick, and J. Hong Global transcriptional profiling demonstrates the combination of type I and type II interferon enhances antiviral and immune responses at clinically relevant doses J Interferon Cytokine Res 25 2005 632
23. T. Walter, J. Dumortier, and O. Guillaud Rejection under alpha interferon therapy in liver transplant recipients Am J Transplant 7 2007 177
24. E. Cholongitas, D. Samonakis, and D. Patch Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus Transplantation 81 2006 488
25. C.M. Stanca, M.I. Fiel, and N. Kontorinis Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin Transplantation 84 2007 180
26. S. Berardi, F. Lodato, and A. Gramenzi High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? Gut 56 2007 237
27. P. Muratori, L. Muratori, and M. Guidi Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C Clin Infect Dis 40 2005 501
28. U. Khettry, W.Y. Huang, and M.A. Simpson Patterns of recurrent hepatitis C after liver transplantation in a recent cohort of patients Hum Pathol 38 2007 443